Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Martin de la Presa"'
Autor:
Shawn Sell, Martin de la Presa, Shambhawi Thakur, Medi Eslani, Joseph Jeffrey, John D. Sheppard, Edward J. Holland, Albert Y. Cheung
Publikováno v:
American journal of ophthalmology.
To compare cryopreserved sutureless amniotic membranes (C-SAM) and dehydrated sutureless amniotic membranes (D-SAM) outpatient treatment outcomes for persistent epithelial defects (PED), analyze risk factors for treatment failure, and identify advers
Publikováno v:
Cornea. 40:99-106
PURPOSE To evaluate the ex vivo safety and efficacy of using paired peripheral incisions to achieve a triple scroll conformation that facilitates unscrolling in Descemet membrane endothelial keratoplasty (DMEK). METHODS The safety of adding paired pe
Publikováno v:
Cornea. 41(6)
PURPOSE The purpose of this study was to report a retrospective case series of anterior scleral and limbal inflammatory necrosis after adjuvant miltefosine for recalcitrant Acanthamoeba keratitis (AK). METHODS A case series and literature review. RES
Publikováno v:
Cornea. 41(2)
Purpose The purpose of this study was to report a case of acute corneal epithelial rejection of living-related conjunctival limbal allograft (LR-CLAL) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Observations A 27-y
Autor:
Martin de la Presa, Emmett F. Carpel
Publikováno v:
JAMA ophthalmology. 137(1)
Autor:
Mitchell D. Barneck, Nathaniel L. Rhodes, Martin de la Presa, John Langell, Ahrash Poursaid, Matthew A. Firpo
Publikováno v:
Lasers in Surgery and Medicine. 48:311-317
Background and Objective Approximately 1.7 million patients are affected by hospital-acquired infections every year in the United States. The increasing prevalence of multidrug-resistant bacteria associated with these infections prompts the investiga
Autor:
James P. Allen, Martin de la Presa, Mitchell D. Barneck, Maziar M. Nourian, Matthew A. Firpo, Nathaniel L. Rhodes, John Langell, Ahrash E. Poursaid
Publikováno v:
The Journal of surgical research. 206(2)
Background The increasing incidence of healthcare-associated infections (HAIs) and multidrug-resistant organisms demonstrate the need for innovative technological solutions. Staphylococcus aureus, Streptococcus pneumonia, Escherichia coli, and Pseudo